Stocks
GlaxoSmithKline (GSK) Debt US GAAP (year values) |
|||||||||
| 2022 | 2022 | 2022 | 2023 | 2023 | LTM ? | CAGR 5 years ? | |||
| Debt, £ | 20 987 000 000 | 20 987 000 000 | 20 987 000 000 | 18 018 000 000 | 18 018 000 000 | 0.000 | |||
| Changes by years, y/y, % | -13% | 0% | 0% | -14% | 0% | -7.1% | |||
GlaxoSmithKline. Debt, £
GlaxoSmithKline. Debt, changes, %
GlaxoSmithKline (GSK) Debt US GAAP (quarter values) |
||||||||
| 2024Q2 | 2024Q1 | 2024Q3 | 2024Q2 | 2024Q3 | LTM ? | |||
| Debt, £ | 16 943 000 000 | 17 772 000 000 | 0.000 | 16 943 000 000 | 0.000 | 0.000 | ||
| Changes by years, y/y, % | -21% | -15% | -100% | -21% | -100% | |||
| Changes by quarters, q/q, % | -6% | +5% | -100% | -100% | ||||
